We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DLHC:NASDAQDLH Holdings Corp. Analysis

Data as of 2026-06-13 - not real-time

$5.51

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading beneath its short‑term and longer‑term moving averages, underscoring a bearish price pattern. It has found a foothold near a recently identified support level, while the next resistance lies modestly higher. Momentum indicators show a neutral RSI and a MACD that has just turned bullish, hinting at a potential short‑term reversal. Recent price action has been relatively volatile, reflecting heightened trader activity. The beta reading suggests the stock moves less than the broader market, tempering systematic risk. Market sentiment, as captured by the fear‑and‑greed gauge, is in the extreme greed zone, indicating strong investor enthusiasm.
On the fundamentals side, revenue has contracted sharply year‑over‑year, and profit margins remain in the negative territory. Operating cash flow stays positive, providing a modest cushion despite the earnings shortfall. The balance sheet is weighted heavily toward debt, resulting in a leverage profile that is considerably above industry norms. Valuation multiples are well below sector averages, with price‑to‑book and price‑to‑sales ratios indicating a sizable discount to intrinsic estimates. A discounted cash‑flow model points to a fair value substantially higher than the current market price, implying a large upside potential. The company does not pay a dividend, and its exposure is concentrated in U.S. federal contracts, which brings both stability and regulatory sensitivity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near support
  • negative earnings and high debt
  • bullish MACD signal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount
  • positive operating cash flow
  • upcoming earnings catalyst

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • reliance on federal contracts
  • debt burden
  • potential upside from DCF valuation

Key Metrics & Analysis

Financial Health

Revenue Growth-33.60%
Profit Margin-1.53%
P/E Ratio-13.4
ROE-4.02%
ROA1.59%
Debt/Equity132.02
P/B Ratio0.7
Op. Cash Flow$19.3M
Free Cash Flow$24.7M
Industry P/E30.6

Technical Analysis

TrendBearish
RSI43.5
Support$5.44
Resistance$5.78
MA 20$5.55
MA 50$5.74
MA 200$5.76
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$12.48
Target Price$10.00
Upside/Downside81.49%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.46
Volatility19.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.